I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 19 studies | 33% ± 14% | |
| astrocyte | 16 studies | 39% ± 16% | |
| oligodendrocyte | 13 studies | 37% ± 13% | |
| glutamatergic neuron | 12 studies | 75% ± 23% | |
| oligodendrocyte precursor cell | 12 studies | 48% ± 16% | |
| GABAergic neuron | 11 studies | 54% ± 26% | |
| microglial cell | 11 studies | 34% ± 9% | |
| adipocyte | 9 studies | 27% ± 5% | |
| dendritic cell | 8 studies | 26% ± 11% | |
| neuron | 7 studies | 50% ± 21% | |
| macrophage | 7 studies | 33% ± 11% | |
| fibroblast | 7 studies | 24% ± 9% | |
| T cell | 7 studies | 20% ± 4% | |
| epithelial cell | 6 studies | 31% ± 12% | |
| interneuron | 6 studies | 63% ± 24% | |
| pericyte | 6 studies | 24% ± 8% | |
| plasmacytoid dendritic cell | 6 studies | 22% ± 5% | |
| mast cell | 5 studies | 21% ± 5% | |
| myeloid cell | 5 studies | 20% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 29% ± 6% | |
| smooth muscle cell | 5 studies | 23% ± 4% | |
| granule cell | 4 studies | 49% ± 17% | |
| B cell | 4 studies | 23% ± 8% | |
| cardiac muscle cell | 4 studies | 22% ± 2% | |
| lymphocyte | 4 studies | 27% ± 9% | |
| amacrine cell | 4 studies | 34% ± 9% | |
| retina horizontal cell | 4 studies | 38% ± 12% | |
| retinal cone cell | 4 studies | 33% ± 9% | |
| retinal rod cell | 4 studies | 34% ± 6% | |
| basal cell | 4 studies | 30% ± 16% | |
| GABAergic interneuron | 3 studies | 60% ± 5% | |
| plasma cell | 3 studies | 33% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| GABAergic amacrine cell | 3 studies | 39% ± 10% | |
| Mueller cell | 3 studies | 27% ± 8% | |
| glycinergic amacrine cell | 3 studies | 37% ± 8% | |
| retinal ganglion cell | 3 studies | 49% ± 9% | |
| endothelial cell of vascular tree | 3 studies | 27% ± 14% | |
| hepatocyte | 3 studies | 36% ± 12% | |
| alveolar macrophage | 3 studies | 26% ± 6% | |
| ciliated cell | 3 studies | 18% ± 1% | |
| monocyte | 3 studies | 28% ± 2% | |
| natural killer cell | 3 studies | 21% ± 4% | |
| goblet cell | 3 studies | 25% ± 11% | |
| transit amplifying cell | 3 studies | 41% ± 25% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% |
